Business Wire

Hyperice Launches Normatec Elite Hips: Dynamic Air Compression Device that Eliminates Hoses and Separate Control Units

14.10.2025 16:00:00 EEST | Business Wire | Press release

Share

Hyperice, a global high-performance wellness brand, today announced the launch of Normatec Elite Hips, the first-ever fully portable dynamic air compression device specifically engineered for the hips, IT bands, and lower back. This standalone device represents a new era of targeted recovery, eliminating the need for separate control units and delivering clinical-grade compression therapy with unprecedented portability and convenience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251014033083/en/

Normatec Elite Hips is the latest addition to the award-winning Normatec lineage. Hyperice reset the industry standard for dynamic air compression therapy with the introduction of Normatec Elite in June 2024, building on the success of the award-winning Normatec 3 line.

Normatec Elite Hips marks an evolution from attachment to an independent device in recovery offerings, transforming how athletes, fitness enthusiasts, and anyone seeking optimal movement can address hip tightness, IT band discomfort, lower back tension, and mobility restrictions. With a sleek, cordless design and gapless compression coverage, the device delivers next-level hip care. Whether caused by intense training, prolonged sitting, or the natural wear of daily activity, hip and lower back problems impact quality of life across all demographics. Normatec provides a science-backed solution that addresses these common challenges with the same technology trusted by professional sports leagues.

"The hips and lower back are the foundation for a lot of movement," said Jim Huether, CEO of Hyperice. “Normatec Elite Hips represents our commitment to making professional-grade recovery technology accessible to everyone. By creating the first standalone hip recovery device with true portability, we're empowering people to take control of their mobility and movement quality wherever they are."

Key Innovation Features:

  • Truly Portable Recovery: No cords, no setup, no limits. What was once an add-on product to traditional Normatec systems is now available as a standalone product. Normatec Elite Hips delivers clinical-grade compression therapy with up to 4 hours of battery life, enabling recovery at home, in the gym, and beyond. The device is TSA-friendly for travel convenience.
  • Seven Levels of Compression: Users can choose from seven intensities (40–110 mmHg) to match their specific needs – whether it's post-workout relief, lower back tension management, or targeted hip activation before activity.
  • Gapless Coverage: Two independent compression zones work together to provide seamless coverage across IT bands, thighs, hamstrings, hips, and lower back, ensuring no missed areas or uneven pressure distribution. Adjustable velcro straps around the leg ensure a secure fit, delivering consistent pressure and optimal results every session.
  • Bluetooth Connection: Bluetooth connectivity to the Hyperice App enables customized settings and personalized protocols.

Engineered for Complete Hip Wellness

Designed by a PhD and a physician bioengineer, the Normatec product line replicates the natural muscle pumps of the body, the one-way valves of the venous system, and peristalsis (cyclical waves of compression) to efficiently mobilize fluid to improve circulation, reduce swelling and inflammation, and accelerate recovery. The patented technology delivers targeted relief that helps users loosen tight hips and lower back, recover faster after workouts, improve range of motion and flexibility, and feel lighter, looser, and more mobile.

"From clinical environments to the locker room and beyond, Normatec has become synonymous with recovery," said Gilad Jacobs, Hyperice Chief Innovation Officer and Normatec Recovery Founder. "Normatec Elite Hips represents the next evolution of our technology – bringing targeted, professional-level hip recovery to anyone who needs it, in a form factor that fits seamlessly into daily life."

Clinical research supports the efficacy of dynamic air compression for recovery and mobility enhancement. A recent study comparing cryotherapy versus dynamic compression in low back pain patients found that while both treatments reduced pain, only dynamic compression improved range of motion across all measured parameters, with statistically significant improvements in lumbar flexion, hip flexion, and trunk mobility.

Normatec Elite Hips is the latest addition to the award-winning Normatec lineage. Hyperice reset the industry standard for dynamic air compression therapy with the introduction of Normatec Elite in June 2024, building on the success of the award-winning Normatec 3 line.

Normatec Elite Hips is available now for $599 USD and CA$799 at hyperice.com, Best Buy, Dick's Sporting Goods, and REI. The device is FSA/HSA eligible, making professional-grade recovery technology more accessible to consumers.

In Europe and the UK, the same cutting-edge technology will be available at hyperice.com as Normatec Premier Hips on November 10, for 599€ and £529.

About Hyperice

Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), contrast therapy (Hyperice X), and Hyperboot collaboration with Nike. Now, as a holistic high-performance wellness brand, Hyperice is designed for all – from the most elite athletes, leagues, and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies and a TIME Best Inventions winner, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance, and workplace wellness on a global scale. For more information, visit hyperice.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251014033083/en/

Contacts

Jack Taylor PR
hyperice@jacktaylorpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release

Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone

OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur

Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release

Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu

From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 16:00:00 EEST | Press release

Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes. “At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably link

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye